Richard Scott Struthers - Feb 12, 2024 Form 4 Insider Report for Crinetics Pharmaceuticals, Inc. (CRNX)

Role
President & CEO, Director
Signature
/s/ Marc Wilson, as attorney-in-fact
Stock symbol
CRNX
Transactions as of
Feb 12, 2024
Transactions value $
$0
Form type
4
Date filed
2/14/2024, 04:28 PM
Previous filing
Nov 13, 2023
Next filing
Mar 6, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRNX Common Stock Gift $0 -60K -9.51% $0.00 571K Feb 12, 2024 By Family Trust 1 F1
transaction CRNX Common Stock Gift $0 +20K +22.22% $0.00 110K Feb 12, 2024 By Family Trust 2 F1
transaction CRNX Common Stock Gift $0 +20K +22.22% $0.00 110K Feb 12, 2024 By Family Trust 3 F1
transaction CRNX Common Stock Gift $0 +20K +22.22% $0.00 110K Feb 12, 2024 By Family Trust 4 F1
holding CRNX Common Stock 186K Feb 12, 2024 Direct
holding CRNX Common Stock 1K Feb 12, 2024 By Spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Bona fide gift made by the Reporting Person for no consideration.